| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |